RecruitingNCT05012228
Molecular Mechanisms of Fibrillin/LTBP Superfamily in Renal Fibrosis and Cardiorenal Syndrome
Molecular Mechanisms of Fibrillin/LTBP Superfamily in Renal Fibrosis and Cardiorenal
Sponsor
National Taiwan University Hospital
Enrollment
30 participants
Start Date
Jul 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This project is to understand the LTBP4 expression in human renal fibrotic tissues. The investigators will exam major location of LTBP4 expression and check any similar or discrepancy in renal fibrosis with different etiologies.
Eligibility
Min Age: 20 Years
Inclusion Criteria1
- Abnormal kidney function, proteinuria, hematuria
Exclusion Criteria1
- N/A
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05012228